Conolidine’s analgesic results stem from its conversation with non-opioid pain pathways. Compared with opioids, which bind to µ-opioid receptors in the central nervous system, conolidine modulates alternate molecular targets. A Science Advances review discovered that conolidine interacts Together with the atypical chemokine receptor ACKR3/CXCR7,… Read More